Trans-channel fluorescence learning improves high-content screening for Alzheimer's disease therapeutics

Abstract: Fluorescent markers in microscopy-based drug screens carry information on how compounds affect biological processes, but practical considerations may hinder their use. Wong et al. develop a deep learning method for generating images in drug discovery, with broad applicability across diverse fluorescence microscopy datasets.
0 Replies
Loading